| A human serotonin transporter mutation causes constitutive activation of transport activity. | |
| | |
MedLine Citation:
|
PMID: 12869649 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A rarely occurring variant of human serotonin transporter (hSERT) was tested for its functional consequences in HeLa and COS-7 cells. The variant, in which Ile-425 is converted to Val, was significantly different from wild type with respect to its catalytic properties. In both cell types, rates of serotonin (5-HT) transport were higher for the I425V variant. Both an increase in Vmax and a decrease in KM caused this increase in rate. The increase in Vmax was not accounted for by increases in transporter expression or in the distribution of transporter between the cell surface and intracellular pools. The decrease in KM was accompanied by a decrease in the KD for binding of the cocaine analog 2beta-carbomethoxy-3beta-(4-[125I]iodophenyl)tropane. In both HeLa and COS-7 cells, the nitric oxide donor S-nitroso-N-acetylpenicillamine increased the activity of wild-type hSERT to that of the variant but did not change the activity of the I425V variant. This stimulation was prevented by the presence of oxyhemoglobin, which quenches nitric oxide, and by an inhibitor of guanylyl cyclase. |
| | |
Authors:
|
Fusun Kilic; Dennis L Murphy; Gary Rudnick |
Related Documents
:
|
17483329 - Monocarboxylate transporter 4 regulates maturation and trafficking of cd147 to the plas... 6826519 - Development of salt-resistant active transport in a moderately halophilic bacterium. 1536839 - Expression of a cloned gamma-aminobutyric acid transporter in mammalian cells. 1085569 - Mitochondria-rich cells of frog skin in transport mechanisms: morphological and kinetic... 12439599 - Tumour cell uptake of the metastasis inhibitor ruthenium complex nami-a and its in vitr... 16652999 - The uptake of (+)-s- and (-)-r-abscisic acid by suspension culture cells of hopbush (do... 7679009 - Erythropoietin-specific cell cycle progression in erythroid subclones of the interleuki... 9698089 - Protective effects of anethole dithiolethione against oxidative stress-induced cytotoxi... 870589 - An autoradiographic analysis of nucleic acid synthesis in the presumptive primordial ge... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Molecular pharmacology Volume: 64 ISSN: 0026-895X ISO Abbreviation: Mol. Pharmacol. Publication Date: 2003 Aug |
Date Detail:
|
Created Date: 2003-07-18 Completed Date: 2003-08-15 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0035623 Medline TA: Mol Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 440-6 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208066, New Haven, CT 06520-8066, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acid Substitution Animals Biological Transport / drug effects Biotinylation COS Cells Carrier Proteins / drug effects, genetics, metabolism* Humans Immunohistochemistry Isoleucine / genetics Kinetics Membrane Glycoproteins / drug effects, genetics, metabolism* Membrane Transport Proteins* Mutagenesis, Site-Directed Nerve Tissue Proteins* Nitric Oxide Donors / pharmacology Serotonin / metabolism* Serotonin Plasma Membrane Transport Proteins Transfection Valine / genetics |
| Chemical | |
Reg. No./Substance:
|
0/Carrier Proteins; 0/Membrane Glycoproteins; 0/Membrane Transport Proteins; 0/Nerve Tissue Proteins; 0/Nitric Oxide Donors; 0/SLC6A4 protein, human; 0/Serotonin Plasma Membrane Transport Proteins; 50-67-9/Serotonin; 7004-03-7/Valine; 73-32-5/Isoleucine |
| Comments/Corrections | |
Comment In:
|
Mol Pharmacol. 2003 Aug;64(2):196-8
[PMID:
12869622
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine ...
Next Document: Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activatio...